Wasserman SI |
Mediators of immediate hypersensitivity. |
1983 |
J. Allergy Clin. Immunol. |
pmid:6193157
|
Hopkins NK et al. |
Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4. |
1983 |
Biochim. Biophys. Acta |
pmid:6313071
|
Stimler NP and O'Flaherty JT |
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. |
1983 |
Am. J. Pathol. |
pmid:6624879
|
Hartung HP |
Acetyl glyceryl ether phosphorylcholine (platelet-activating factor) mediates heightened metabolic activity in macrophages. Studies on PGE, TXB2 and O2- production, spreading, and the influence of calmodulin-inhibitor W-7. |
1983 |
FEBS Lett. |
pmid:6309563
|
Shukla SD et al. |
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. |
1983 |
J. Biol. Chem. |
pmid:6309795
|
Hornby EJ and Perry CR |
1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. |
1983 |
Thromb. Haemost. |
pmid:6636035
|
Patterson R and Harris KE |
The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys. |
1983 |
J. Lab. Clin. Med. |
pmid:6644157
|
Nunn B |
Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. |
1983 |
Thromb. Res. |
pmid:6648898
|
Myers A et al. |
Glucocorticoid protection against PAF-acether toxicity in mice. |
1983 |
Br. J. Pharmacol. |
pmid:6652344
|
Cervoni P et al. |
Aortic vascular and atrial responses to (+/-)-1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine. |
1983 |
Br. J. Pharmacol. |
pmid:6652348
|
Ogihara T et al. |
[Renomedullary hypotensive lipids and prostaglandins]. |
1983 |
Horumon To Rinsho |
pmid:6368051
|
Chilton FH et al. |
Metabolic fate of platelet-activating factor in neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6853486
|
Stormorken H et al. |
A new bleeding disorder: lack of platelet aggregatory response to adrenaline and lack of secondary aggregation to ADP and platelet activating factor (PAF). |
1983 |
Thromb. Res. |
pmid:6857589
|
Kloprogge E et al. |
Stimulus-response coupling in human platelets. Evidence against a role of PAF-acether in the "third pathway'. |
1983 |
Thromb. Res. |
pmid:6857605
|
Chilton FH et al. |
Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6408071
|
Lecrubier C et al. |
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. |
1983 |
Agents Actions |
pmid:6858789
|
Gonzalez-Crussi F and Hsueh W |
Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. |
1983 |
Am. J. Pathol. |
pmid:6859226
|
Hubbard JW et al. |
Antihypertensive effects of I-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine on plasma renin activity and catecholamine responses in spontaneously hypertensive rats. |
1983 |
Life Sci. |
pmid:6337313
|
Acharya SB and MacIntyre DE |
Platelet products and vascular PGI2 production. |
1983 |
Prostaglandins Leukot Med |
pmid:6338532
|
Camussi G et al. |
Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia. |
1983 |
Immunology |
pmid:6339375
|